To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.
NCT03414333
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Glucose Metabolism Disorders
Obesity
Degenerative Brain Disorder
Interventions
PROCEDURE:
RYGB
DRUG:
GLP-1
Sponsor
University of Pisa